© The Rockefeller University Press, 0022-1007/1997/11/1775/ $5.00
The Journal of Experimental Medicine, Volume 186, Number 10, November 17, 1997 1775-1779
Quantitative Contribution of CD4 and CD8 to T Cell Antigen Receptor Serial Triggering
Antonella Viola*,
Mariolina Salio*,
Loretta Tuosto
,
Susanne Linkert*,
Oreste Acuto, and
Antonio Lanzavecchia*
From the * Basel Institute for Immunology, 4005, Basel, Switzerland; and Molecular Immunology Unit Institut Pasteur, 75724 Paris Cedex 15, France
 |
Abstract
|
|---|
CD4 and CD8 are thought to function as coreceptors by binding to the cognate major histocompatibility complex (MHC) molecules recognized by the T cell antigen receptor (TCR) and initiating the signal transduction cascade. We report that during T cell–antigen-presenting cell interaction, triggered TCRs and coreceptors are downregulated and degraded with identical kinetics. This coordinated disappearance takes place whenever the TCR is triggered, even when the coreceptor does not engage the cognate MHC molecule and is the consequence of binding of the coreceptor-associated Lck to ZAP-70. The interaction of coreceptor and cognate MHC molecules is dispensable when T cells are stimulated by optimal ligands, but becomes crucial when suboptimal ligands are used. In the latter case the coreceptor increases the efficiency of TCR triggering without changing the activation threshold or the quality of the T cell response.
Address correspondence to Antonella Viola, Basel Institute for Immunology, Grenzacherstrasse 487, CH4005, Basel, Switzerland. Phone: 41-61-605-1210; FAX: 41-61-605-1222; E-mail: viola{at}bii.ch
Because of their capacity to bind to the same MHC molecule as that engaged by the TCR (1, 2), and because of their association with the tyrosine kinase Lck (3), CD4 and CD8 have been defined as coreceptors (4, 5). The binding of coreceptor to the cognate MHC molecule is thought to perform two functions: (a) to stabilize the TCR– peptide MHC interaction (6–8); and (b) to carry Lck in contact with the TCR to initiate phosphorylation events (9). Indeed, cross-linking of TCRs and coreceptors results in enhanced T cell response (10, 11), whereas interference with the coreceptor–MHC interaction inhibits T cell activation or changes the quality of the response (12–14).
However, there are clear cases where the interaction of coreceptors with cognate MHC molecules appears to be dispensable for full T cell activation (15). These findings raise the question of whether the contribution of the coreceptor to T cell activation is qualitative, in the sense that it provides signals additional to and different from those provided by TCR alone, or whether the coreceptor acts by facilitating the triggering of TCRs when the interaction has lower than optimal kinetics.
We report that during T cell–APC interaction, the coreceptors are recruited to triggered TCRs and are downregulated with identical kinetics, even when the coreceptor does not engage the cognate MHC molecule. This process is the consequence of the binding of coreceptor-associated Lck to ZAP-70/
and takes place whenever the TCR is triggered. We also show that the contribution of the coreceptors becomes crucial when suboptimal ligands are used. In this case, engagement of the coreceptor with the cognate MHC molecule increases the efficiency of serial TCR triggering without changing the activation threshold or the quality of the T cell response.
|
Materials and Methods
|
|---|
T Cell Clones.
HLA-DR1101–restricted (KS140, KS70, and KS164) and DR1302-restricted (AL15.1) CD4+ T cell clones specific for tetanus toxin (TT)830-843 peptide and HLA-A2– restricted CD8+clones (CER22, CER43) specific for the influenza matrix (M) 58–66 peptide were used. T cell clones were conjugated with EBV-transformed B (EBV-B) cells pulsed with various concentrations of either peptide or bacterial superantigens (toxic shock syndrome toxin or staphylococcal enterotoxin B) or monovalent anti-CD3 antibodies (W632/T3 or L243/T3) as described (16). CD4+CD8+ alloreactive T cell clones were isolated by sorting double positive cells from a primary MLR. CD8+ alloreactive T cell clones that recognize class II molecules on the class I– EBV-B .221 cells were generated, stimulating PBMC with irradiated .221 cells, followed by sorting and cloning of the CD8+CD4– cells. The class II specificity of the clones was verified using a panel of typed EBV-B cells as well as inhibition by anti–class II antibodies.
FACS® Analysis.
T cells were conjugated with autologous EBV-B cells pulsed with peptide, superantigen, or anti-CD3 for 5 h at 37°C. Downregulation and degradation of TCR/CD3 and coreceptors were measured by indirect immunofluorescence on intact and permeabilized cells as previously described (17, 18) using antibodies to CD3 (OKT3 or Leu3a), CD4 (6D10), and CD8 (OKT8). The absolute numbers of CD3, CD4, and CD8 molecules per cell were estimated by reference to a standard curve of beads coated with known amounts of mouse Ig (Flow Cytometry Standards Europe, Leiden, The Netherlands).
Immunoprecipitations and Kinase Assays.
T cells were stimulated or not with the appropriate APC for 2 min at 37°C and lysed for 30 min at 4°C in 1% Brij96 buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM MgCl2, and 1 mM EGTA) in the presence of protease and phosphatase inhibitors (10 µg/ml aprotinin, 10 µg/ml leupeptin, 1 mM Pefabloc-SC, 50 mM NaF, 10 mM Na4P2O7, and 1 mM NaVO4). CD4 immunoprecipitation, in vitro kinase assay, and reimmunoprecipitation with anti–ZAP-70 or anti- were performed as previously described (19, 20) using the following antibodies: 19Thy-5D7 (IgG2a, anti-CD4), 21Thy-2D3 (IgG1, anti-CD8), and rabbit polyclonal antibodies to ZAP-70 and .
Drugs and Transfection.
Genistein and herbimycin A were purchased from Calbiochem (La Jolla, CA) and used as previously described (21). After overnight treatment with herbimycin, which is required to deplete Lck, the expression of coreceptor was reduced by 
50%. cDNAs encoding wild-type human CD4 and the mutant CD4.401 molecule that does not associate with Lck were a gift of Dr. Dan Littman (Skirball Institute of Biomolecular Medicine, NYU Medical Center, New York; reference 22). The cDNA was subcloned in the pSAM-EN retroviral vector (23) using the SalI–XhoI restriction sites. Plasmid DNA was purified and transfected in the amphotropic packaging cell line PA317 as previously described (22). The transduction of Jurkat cells was done as previously described (22).
Substituted Peptides and Anticoreceptor Antibodies.
Several substituted analogs of TT830-843 were tested for their capacity to trigger T cell proliferation, and peptides with unaltered capacity to bind to DR molecules but weaker T cell stimulatory capacity were selected. Blocking anti-CD4 antibodies (M-T310, M-T413, M-T414, and M-T435) and anti-CD8 (733) were a gift of Dr. E.P. Rieber (Institute of Immunology, Technical University Dresden, Germany) and Dr. E. Roosnek (University Hospital, Geneva, Switzerland). Antibodies were used in the culture at 10 µg/ml.
|
Results
|
|---|
Parallel Downregulation and Degradation of the Coreceptor and TCR.
To understand the contribution of the coreceptor to TCR triggering and T cell activation, we studied the TCR–coreceptor interaction in T cells stimulated by a specific ligand. It has been shown that, after triggering by agonists, TCRs are downregulated and degraded and this downregulation can be used to measure the number of TCRs triggered (17, 18). Therefore, we investigated whether the CD4 or CD8 coreceptors would also be downregulated together with the TCR. We observed that in specific T–APC conjugates, TCRs and coreceptors are downregulated with the same kinetics and with fixed stoichiometry (Fig. 1, A and B). In addition, downregulation is followed by rapid degradation of both coreceptor and TCR (Fig. 1 C). By reference to a standard curve of Ig-coated beads, we estimated that approximately two CD4 or four CD8 molecules are downregulated for each TCR (data not shown), an estimate which is consistent with that reported for CD4 by Saizawa and Janeway (24).
Intracellular Recruitment of Coreceptor to Triggered TCRs in the Absence of an Interaction with Cognate or Noncognate MHC Molecules.
We investigated whether the codownregulation of TCR and coreceptor would require the interaction between coreceptor and cognate MHC molecule or whether it would simply be a consequence of TCR triggering. Three lines of evidence indicate that coreceptor downregulation can occur in the absence of interaction with the cognate MHC molecule. First, a parallel downregulation of TCR and coreceptor was induced not only by specific peptide–MHC complexes, but also by bacterial superantigens or monovalent anti-CD3 antibodies (Fig. 2, A and B). Second, class I–restricted T cell clones expressing both CD4 and CD8 downregulated both coreceptors to the same extent (Fig. 2 C). Third, class II–alloreactive CD8+ T cell clones, when stimulated by class II+ APCs lacking class I molecules, downregulated CD8 together with TCR (Fig. 2 D).
The mechanism responsible for the downregulation of the coreceptor was next investigated. Three lines of evidence indicate that the downregulation of the coreceptor was due to an intracellular association with triggered TCRs. First, immunoprecipitation experiments showed that, as previously demonstrated in Jurkat cells activated by anti-CD3 antibodies (19, 20), a complex-containing coreceptor, Lck and ZAP-70, is formed after T cell activation by a specific ligand (Fig. 3 A). Comparable results were obtained when the reimmunoprecipitation was performed with either anti–ZAP-70 or anti-. Second, treatment with the Lck inhibitors genistein or herbimycin A does not interfere with TCR downregulation, but completely inhibits coreceptor downregulation (data not shown). Third, truncated CD4 molecules that fail to associate with Lck are not downregulated with triggered TCRs (Fig. 3 B).
Quantitative Contribution of Coreceptor to TCR Triggering and T Cell Activation.
Taken together, the above results demonstrate that coreceptors become associated to, and are downregulated together with, triggered TCRs, and that this process can occur after TCR triggering, even in the absence of interaction of the coreceptor with the cognate MHC molecules. However, these results do not explain how coreceptors contribute to T cell antigen recognition in most cases. Considering the serial engagement model (25), it is conceivable that the requirement for coreceptor might vary with the kinetics of the TCR–ligand interaction. Although ligands with optimal kinetics might efficiently trigger TCRs even in the absence of coreceptor, ligands with higher off-rates may require the extracellular interaction of the coreceptor with the cognate molecule to increase the stability of the complex and, consequently, the rate of triggering.
To address this point, we stimulated T cell clones with ligands of different potency and tested the effect of CD4 or CD8 antibodies on the extent of TCR triggering, the T cell activation threshold, and the quality of the response. As shown in Fig. 4, the proliferative response of T cell clone KS70 was not affected by anti-CD4 antibody when the clone was triggered by the bacterial superantigen TSST, but was inhibited by anti-CD4 when the clone was triggered by peptide–MHC complexes. Interestingly, clone KS164, which displayed a better dose–response curve to the same peptide–DR complex, was not inhibited by anti-CD4. However, this clone became sensitive to inhibition when a modified peptide with weaker agonistic properties was used. Comparable results were obtained with two additional CD4+ and two additional CD8+ clones, indicating that the sensitivity to inhibition by anticoreceptor antibodies is inversely correlated to the efficiency of the TCR–ligand interaction.
To investigate whether the lower response of T cells in the presence of anti-CD4 antibodies reflects a lower extent of TCR triggering or, rather, an altered signal leading to qualitatively different responses, we correlated TCR downregulation and cytokine production in T cells stimulated by strong or weak agonists in the presence or absence of anti-CD4 antibodies. As shown in Fig. 5, the inhibition of T cell response by anti-CD4 antibodies precisely correlated with a reduced level of TCR downregulation both when strong and weak agonists were used. These results indicate that the anti-CD4 antibody mimics the effect of a weak agonist, i.e., results in a decreased efficiency of serial triggering. However, in spite of a decreased efficiency of TCR triggering, the threshold of T cell activation and the type of cytokines produced were not affected by anti-CD4. Indeed, T cells produced IFN-
, IL-2, and TNF-
when 20–30% of TCRs were triggered, irrespective of the strength of the agonist and of the presence or absence of anti-CD4. IL-3 production consistently required higher levels of TCR occupancy, which were comparable in all experimental conditions.
|
Discussion
|
|---|
Our results reconcile several apparently contradictory observations concerning coreceptor dependency and the role of extracellular and intracellular interactions in coreceptor function. We have shown that in T cells activated by peptide–MHC, superantigens, or anti-CD3 antibodies the coreceptors are recruited to triggered TCRs and are downregulated and degraded together with them. This process does not necessarily require the interaction of the coreceptor with the cognate MHC molecule, but takes place whenever the TCR is triggered via the intracellular association of Lck and ZAP-70/.
It is interesting that even in unstimulated T cell clones and ZAP-70 can be immunoprecipitated by anti-CD4 or anti-CD8 antibodies, although the complexes contain only low levels of kinase activity. This finding suggests that in human as well as mouse T cells a fraction of TCRs is constitutively associated with the coreceptor (26). This association may be responsible for the constitutive association of phospho- and ZAP-70 observed in thymocytes and lymph node T cells (27). It is tempting to speculate that the constitutive association of TCR and coreceptors might play a role in inducing positive selection by self-ligands in the thymus as well as in facilitating the response to low-affinity ligands in periphery.
There is clear evidence that coreceptor can stabilize the TCR/peptide–MHC interaction (6–8). We have shown here that this stabilization may actually result in an increased rate of TCR triggering. Indeed, the coreceptor appears to be dispensable when the ligands have optimal kinetics, allowing efficient serial TCR triggering. However, the binding of coreceptor to cognate MHC molecules becomes critical in the case of low-affinity ligands because in this case the coreceptor can initially stabilize the TCR–ligand interaction, thus increasing the probability that an engagement event will result in triggering.
Our results also show that coreceptors play a quantitative role in T cell activation. Indeed the reduced response observed in cultures stimulated with suboptimal ligands or in the presence of anticoreceptor antibodies can be fully accounted for by a reduced level of TCR triggering. The fact that the T cell activation thresholds and the profile of cytokines produced are comparable in all conditions of stimulation is not surprising. Indeed, in all cases the triggered TCRs have been shown to be complexed with coreceptors, suggesting similar composition and transduction capacity of the signaling complexes.
|
Acknowledgments
|
|---|
We thank E.P. Rieber and E. Roosnek for providing blocking anti-CD4 and anti-CD8 antibodies, D. Littmann for providing CD4 constructs, and K. Karjalainen and M. Cella for critical reading and comments.
Submitted: 9 July 1997
Revised: 12 September 1997
The Basel Institute for Immunology was founded and is supported by F. Hoffmann La Roche Ltd., Basel, Switzerland.
|
References
|
|---|
1 Doyle C & Strominger JL. Interaction between CD4 and class II MHC molecules mediated cell adhesion, Nature (Lond), 1987, 330, 256–259.[Medline]
2 Norment AM, Salter RD, Parham P, Engelhard VH & Littman DR. Cell–cell adhesion mediated by CD8 and MHC class I molecules, Nature (Lond), 1988, 336, 79–81.[Medline]
3 Veillette A, Bookman MA, Horak EM & Bolen JB. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck, Cell, 1988, 55, 301–308.[Medline]
4 Janeway CA Jr. T cell development. Accessories or coreceptors? , Nature (Lond), 1988, 335, 208–210.[Medline]
5 Janeway CA Jr. The co-receptor function of CD4, Semin Immunol, 1991, 3, 153–160.[Medline]
6 Luescher IF, Vivier E, Layer A, Mahiou J, Godeau F, Malissen B & Romero P. CD8 modulation of T cell antigen receptor–ligand interactions on living cytotoxic T lymphocytes, Nature (Lond), 1995, 373, 353–356.[Medline]
7 Renard V, Romero P, Vivier E, Malissen B & Luescher IF. CD8β increases CD8 coreceptor function and participation in TCR–ligand binding, J Exp Med, 1996, 184, 2439–2444.[Abstract/Free Full Text]
8 Garcia KC, Scott CA, Brunmark A, Carbone FR, Peterson PA, Wilson IA & Teyton L. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes [see comments], Nature (Lond), 1996, 384, 577–581.[Medline]
9 Weiss A & Littman DR. Signal transduction by lymphocyte antigen receptors, Cell, 1994, 76, 263–274.[Medline]
10 Emmrich F, Strittmatter U & Eichmann K. Synergism in the activation of human CD8 T cells by cross-linking the T-cell receptor complex with the CD8 differentiation antigen, Proc Natl Acad Sci USA, 1986, 83, 8298–8302.[Abstract/Free Full Text]
11 Janeway CA Jr & Bottomly K. Signals and signs for lymphocyte responses, Cell, 1994, 76, 275–285.[Medline]
12 Madrenas J, Chau LA, Smith J, Bluestone JA & Germain RN. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide–MHC molecule ligands, J Exp Med, 1997, 185, 219–229.[Abstract/Free Full Text]
13 Vidal K, Hsu BL, Williams CB & Allen PM. Endogenous altered peptide ligands can affect peripheral T cell responses, J Exp Med, 1996, 183, 1311–1321.[Abstract/Free Full Text]
14 Mannie MD, Rosser JM & White GA. Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition, J Immunol, 1995, 154, 2642–2654.[Abstract]
15 Cerundolo V, Tse AG, Salter RD, Parham P & Townsend A. CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68.1, Proc R Soc Lond B Biol Sci, 1991, 244, 169–177.[Abstract/Free Full Text]
16 Viola A & Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds [see comments], Science (Wash DC), 1996, 273, 104–106.[Abstract]
17 Valitutti S, Muller S, Cella M, Padovan E & Lanzavecchia A. Serial triggering of many T cell receptors by a few peptide–MHC complexes [see comments], Nature (Lond), 1995, 375, 148–151.[Medline]
18 Valitutti S, Muller S, Salio M & Lanzavecchia A. Degradation of T cell receptor (TCR)–CD3- complexes after antigenic stimulation, J Exp Med, 1997, 185, 1859–1864.[Abstract/Free Full Text]
19 Thome M, Duplay P, Guttinger M & Acuto O. Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor–CD3/ complex, J Exp Med, 1995, 181, 1997–2006.[Abstract/Free Full Text]
20 Thome M, Germain V, DiSanto JP & Acuto O. The p56lck SH2 domain mediates recruitment of CD8/ p56lck to the activated T cell receptor/CD3/ complex, Eur J Immunol, 1996, 26, 2093–2100.[Medline]
21 Salio M, Valitutti S & Lanzavecchia A. Agonist-induced TCR downregulation: molecular requirements and dissociation from T cell activation, Eur J Immunol, 1997, 27, 1769–1773.[Medline]
22 Bedinger P, Moriarty A, von Borstel RC II, Donovan NJ, Steimer KS & Littman DR. Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4, Nature (Lond), 1988, 334, 162–165.[Medline]
23 Candotti F, Oakes SA, Johnston JA, Notarangelo LD, O'Shea JJ & Blaese RM. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction, J Exp Med, 1996, 183, 2687–2692.[Abstract/Free Full Text]
24 Saizawa K & Janeway CA Jr. Evidence for a physical association of CD4 and the CD3::β T-cell receptor, Nature (Lond), 1987, 328, 260–263.[Medline]
25 Valitutti S & Lanzavecchia A. Serial triggering of T-cell receptors: a basis for the sensitivity and specificity of T cell antigen recognition, Immunol Today, 1997, 18, 299–304.[Medline]
26 Diez-Orejas R, Ballester S, Feito MJ, Ojeda G, Criado G, Ronda M, Portoles P & Rojo JM. Genetic and immunochemical evidence for CD4-dependent association of p56lck with the β T-cell receptor (TCR): regulation of TCR-induced activation, EMBO (Eur Mol Biol Organ) J, 1994, 13, 90–99.[Medline]
27 van Oers NSC, Killeen N & Weiss A. ZAP-70 is constitutively associated with tyrosine-phosphorylated TCR in murine thymocytes and lymph node T cells, Immunity, 1994, 1, 675–685.[Medline]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
-
Machlenkin, A., Uzana, R., Frankenburg, S., Eisenberg, G., Eisenbach, L., Pitcovski, J., Gorodetsky, R., Nissan, A., Peretz, T., Lotem, M.
(2008). Capture of Tumor Cell Membranes by Trogocytosis Facilitates Detection and Isolation of Tumor-Specific Functional CTLs. Cancer Res.
68: 2006-2013
[Abstract]
[Full Text]
-
Laugel, B., van den Berg, H. A., Gostick, E., Cole, D. K., Wooldridge, L., Boulter, J., Milicic, A., Price, D. A., Sewell, A. K.
(2007). Different T Cell Receptor Affinity Thresholds and CD8 Coreceptor Dependence Govern Cytotoxic T Lymphocyte Activation and Tetramer Binding Properties. J. Biol. Chem.
282: 23799-23810
[Abstract]
[Full Text]
-
Thedrez, A., de Lalla, C., Allain, S., Zaccagnino, L., Sidobre, S., Garavaglia, C., Borsellino, G., Dellabona, P., Bonneville, M., Scotet, E., Casorati, G.
(2007). CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells. Blood
110: 251-258
[Abstract]
[Full Text]
-
Kienzle, N., Olver, S., Buttigieg, K., Groves, P., Janas, M. L., Baz, A., Kelso, A.
(2005). Progressive Differentiation and Commitment of CD8+ T Cells to a Poorly Cytolytic CD8low Phenotype in the Presence of IL-4. J. Immunol.
174: 2021-2029
[Abstract]
[Full Text]
-
Tavano, R., Gri, G., Molon, B., Marinari, B., Rudd, C. E., Tuosto, L., Viola, A.
(2004). CD28 and Lipid Rafts Coordinate Recruitment of Lck to the Immunological Synapse of Human T Lymphocytes. J. Immunol.
173: 5392-5397
[Abstract]
[Full Text]
-
Badran, B. M., Wolinsky, S. M., Burny, A., Willard-Gallo, K. E.
(2002). Identification of Three NFAT Binding Motifs in the 5'-Upstream Region of the Human CD3gamma Gene That Differentially Bind NFATc1, NFATc2, and NF-kappa B p50. J. Biol. Chem.
277: 47136-47148
[Abstract]
[Full Text]
-
Cawthon, A. G., Alexander-Miller, M. A.
(2002). Optimal Colocalization of TCR and CD8 as a Novel Mechanism for the Control of Functional Avidity. J. Immunol.
169: 3492-3498
[Abstract]
[Full Text]
-
Tuosto, L., Marinari, B., Piccolella, E.
(2002). CD4-Lck Through TCR and in the Absence of Vav Exchange Factor Induces Bax Increase and Mitochondrial Damage. J. Immunol.
168: 6106-6112
[Abstract]
[Full Text]
-
Jager, E., Salter, R., Castelli, C., Hohn, H., Freitag, K., Karbach, J., Neukirch, C., Necker, A., Knuth, A., Maeurer, M. J.
(2002). Impact of Antigen Presentation on TCR Modulation and Cytokine Release: Implications for Detection and Sorting of Antigen-Specific CD8+ T Cells Using HLA-A2 Wild-Type or HLA-A2 Mutant Tetrameric Complexes. J. Immunol.
168: 2766-2772
[Abstract]
[Full Text]
-
Utermohlen, O., Schulze-Garg, C., Warnecke, G., Gugel, R., Lohler, J., Deppert, W.
(2001). Simian Virus 40 Large-T-Antigen-Specific Rejection of mKSA Tumor Cells in BALB/c Mice Is Critically Dependent on both Strictly Tumor-Associated, Tumor-Specific CD8+ Cytotoxic T Lymphocytes and CD4+ T Helper Cells. J. Virol.
75: 10593-10602
[Abstract]
[Full Text]
-
Maile, R., Wang, B., Schooler, W., Meyer, A., Collins, E. J., Frelinger, J. A.
(2001). Antigen-Specific Modulation of an Immune Response by In Vivo Administration of Soluble MHC Class I Tetramers. J. Immunol.
167: 3708-3714
[Abstract]
[Full Text]
-
Diepolder, H. M., Gruener, N. H., Gerlach, J. T., Jung, M.-C., Wierenga, E. A., Pape, G. R.
(2001). Different Levels of T-Cell Receptor Triggering Induce Distinct Functions in Hepatitis B and Hepatitis C Virus-Specific Human CD4+ T-Cell Clones. J. Virol.
75: 7803-7810
[Abstract]
[Full Text]
-
Bryl, E., Gazda, M., Foerster, J., Witkowski, J. M.
(2001). Age-related increase of frequency of a new, phenotypically distinct subpopulation of human peripheral blood T cells expressing lowered levels of CD4. Blood
98: 1100-1107
[Abstract]
[Full Text]
-
Derby, M. A., Wang, J., Margulies, D. H., Berzofsky, J. A.
(2001). Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining. Int Immunol
13: 817-824
[Abstract]
[Full Text]
-
Harder, T., Kuhn, M.
(2000). Selective Accumulation of Raft-Associated Membrane Protein Lat in T Cell Receptor Signaling Assemblies. JCB
151: 199-208
[Abstract]
[Full Text]
-
Lennon, G. P., Sillibourne, J. E., Furrie, E., Doherty, M. J., Kay, R. A.
(2000). Antigen Triggering Selectively Increases TCRBV Gene Transcription. J. Immunol.
165: 2020-2027
[Abstract]
[Full Text]
-
Bagriacik, E. U., Klein, J. R.
(2000). The Thyrotropin (Thyroid-Stimulating Hormone) Receptor Is Expressed on Murine Dendritic Cells and on a Subset of CD45RBhigh Lymph Node T Cells: Functional Role for Thyroid-Stimulating Hormone During Immune Activation. J. Immunol.
164: 6158-6165
[Abstract]
[Full Text]
-
Wiegers, G. J., Stec, I. E. M., Klinkert, W. E. F., Reul, J. M. H. M.
(2000). Glucocorticoids Regulate TCR-Induced Elevation of CD4: Functional Implications. J. Immunol.
164: 6213-6220
[Abstract]
[Full Text]
-
Lechner, F., Wong, D. K.H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., Walker, B. D.
(2000). Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus. JEM
191: 1499-1512
[Abstract]
[Full Text]
-
Rogers, P. R., Croft, M.
(2000). CD28, Ox-40, LFA-1, and CD4 Modulation of Th1/Th2 Differentiation Is Directly Dependent on the Dose of Antigen. J. Immunol.
164: 2955-2963
[Abstract]
[Full Text]
-
Casares, S., Zong, C. S., Radu, D. L., Miller, A., Bona, C. A., Brumeanu, T.-D.
(1999). Antigen-Specific Signaling by a Soluble, Dimeric Peptide/Major Histocompatibility Complex Class II/Fc Chimera Leading to T Helper Cell Type 2 Differentiation. JEM
190: 543-554
[Abstract]
[Full Text]
-
Couedel, C., Bodinier, M., Peyrat, M.-A., Bonneville, M., Davodeau, F., Lang, F.
(1999). Selection and Long-Term Persistence of Reactive CTL Clones During an EBV Chronic Response Are Determined by Avidity, CD8 Variable Contribution Compensating for Differences in TCR Affinities. J. Immunol.
162: 6351-6358
[Abstract]
[Full Text]
-
Vallejo, A. N., Brandes, J. C., Weyand, C. M., Goronzy, J. J.
(1999). Modulation of CD28 Expression: Distinct Regulatory Pathways During Activation and Replicative Senescence. J. Immunol.
162: 6572-6579
[Abstract]
[Full Text]
-
Bachmann, M. F., Gallimore, A., Linkert, S., Cerundolo, V., Lanzavecchia, A., Kopf, M., Viola, A.
(1999). Developmental Regulation of Lck Targeting to the CD8 Coreceptor Controls Signaling in Naive and Memory T Cells. JEM
189: 1521-1530
[Abstract]
[Full Text]
-
Itoh, Y., Hemmer, B., Martin, R., Germain, R. N.
(1999). Serial TCR Engagement and Down-Modulation by Peptide:MHC Molecule Ligands: Relationship to the Quality of Individual TCR Signaling Events. J. Immunol.
162: 2073-2080
[Abstract]
[Full Text]
-
Thatte, J., Qadri, A., Radu, C., Ward, E. S.
(1999). Molecular Requirements for T Cell Recognition by a Major Histocompatibility Complex Class II-restricted T Cell Receptor: The Involvement of the Fourth Hypervariable Loop of the V{alpha} Domain. JEM
189: 509-520
[Abstract]
[Full Text]
-
Viola, A., Schroeder, S., Sakakibara, Y., Lanzavecchia, A.
(1999). T Lymphocyte Costimulation Mediated by Reorganization of Membrane Microdomains. Science
283: 680-682
[Abstract]
[Full Text]
-
LANZAVECCHIA, A.
(1999). Three Signals and a Master Switch in the Regulation of T-cell Immunity. Cold Spring Harb Symp Quant Biol
64: 253-258
[Abstract]
-
Mostaghel, E. A., Riberdy, J. M., Steeber, D. A., Doyle, C.
(1998). Coreceptor-Independent T Cell Activation in Mice Expressing MHC Class II Molecules Mutated in the CD4 Binding Domain. J. Immunol.
161: 6559-6566
[Abstract]
[Full Text]
-
Hamad, A. R. A., O'Herrin, S. M., Lebowitz, M. S., Srikrishnan, A., Bieler, J., Schneck, J., Pardoll, D.
(1998). Potent T Cell Activation with Dimeric Peptide-Major Histocompatibility Complex Class II Ligand: The Role of CD4 Coreceptor. JEM
188: 1633-1640
[Abstract]
[Full Text]
-
Leitenberg, D., Boutin, Y., Constant, S., Bottomly, K.
(1998). CD4 Regulation of TCR Signaling and T Cell Differentiation Following Stimulation with Peptides of Different Affinities for the TCR. J. Immunol.
161: 1194-1203
[Abstract]
[Full Text]
-
Tomita, K., Saijo, K., Yamasaki, S., Iida, T., Nakatsu, F., Arase, H., Ohno, H., Shirasawa, T., Kuriyama, T., O'Shea, J. J., Saito, T.
(2001). Cytokine-independent Jak3 Activation upon T Cell Receptor (TCR) Stimulation through Direct Association of Jak3 and the TCR Complex. J. Biol. Chem.
276: 25378-25385
[Abstract]
[Full Text]
Top
Abstract
Materials and Methods
) downregulation in clone KS140 stimulated with APCs pulsed with 10 nM TT830-842. (B) CD3 (•) and CD8 (
) downregulation in clone CER22 stimulated with APCs pulsed with 100 nM M58-66. (C) Surface and total levels of CD3 and CD4 as determined by staining before and after permeabilization in KS70 cells conjugated for 5 h with APCs unpulsed (empty bars) or pulsed with 0.1 µM (hatched bars) or 10 µM (filled bars) TT830-842.
). (C) Downregulation of CD3 versus CD4 (
) and CD8 (
, 